241 related articles for article (PubMed ID: 38284709)
1. Emerging Lipid-based Carriers for Systematic Utilization in the Pharmaceutical and Biomedical Sciences: A Review.
N Kendre P; R Kayande D; P Pote A; B Kanthale S; G Prajapati B; Kendre Y; Jain S
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38284709
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
3. Lipid-based Nanoparticulate Drug Delivery.
Gandhi S; Shastri DH
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38185889
[TBL] [Abstract][Full Text] [Related]
4. Exploring LIPIDs for their potential to improves bioavailability of lipophilic drugs candidates: A review.
Preeti ; Sambhakar S; Saharan R; Narwal S; Malik R; Gahlot V; Khalid A; Najmi A; Zoghebi K; Halawi MA; Albratty M; Mohan S
Saudi Pharm J; 2023 Dec; 31(12):101870. PubMed ID: 38053738
[TBL] [Abstract][Full Text] [Related]
5. Advanced Drug Carriers: A Review of Selected Protein, Polysaccharide, and Lipid Drug Delivery Platforms.
Jamroży M; Kudłacik-Kramarczyk S; Drabczyk A; Krzan M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255859
[TBL] [Abstract][Full Text] [Related]
6. Rationale utilization of phospholipid excipients: a distinctive tool for progressing state of the art in research of emerging drug carriers.
Jebastin K; Narayanasamy D
J Liposome Res; 2023 Mar; 33(1):1-33. PubMed ID: 35543241
[TBL] [Abstract][Full Text] [Related]
7. Nanosize drug delivery system.
Mukherjee B
Curr Pharm Biotechnol; 2013; 14(15):1221. PubMed ID: 25106648
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles and nanostructured lipid carriers: a review of the methods of manufacture and routes of administration.
Akbari J; Saeedi M; Ahmadi F; Hashemi SMH; Babaei A; Yaddollahi S; Rostamkalaei SS; Asare-Addo K; Nokhodchi A
Pharm Dev Technol; 2022 Jun; 27(5):525-544. PubMed ID: 35635506
[TBL] [Abstract][Full Text] [Related]
9. Perspectives and Prospective on Solid Lipid Nanoparticles as Drug Delivery Systems.
Madkhali OA
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268643
[TBL] [Abstract][Full Text] [Related]
10. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic.
Puri A; Loomis K; Smith B; Lee JH; Yavlovich A; Heldman E; Blumenthal R
Crit Rev Ther Drug Carrier Syst; 2009; 26(6):523-80. PubMed ID: 20402623
[TBL] [Abstract][Full Text] [Related]
11. Lipid-Based Nanoparticles as Oral Drug Delivery Systems: Overcoming Poor Gastrointestinal Absorption and Enhancing Bioavailability of Peptide and Protein Therapeutics.
Mehrdadi S
Adv Pharm Bull; 2024 Mar; 14(1):48-66. PubMed ID: 38585451
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Potential Applications of Lipid Nanoparticles in Medicine.
Musielak E; Feliczak-Guzik A; Nowak I
Materials (Basel); 2022 Jan; 15(2):. PubMed ID: 35057398
[TBL] [Abstract][Full Text] [Related]
13. Advancements and prospects of lipid-based nanoparticles: dual frontiers in cancer treatment and vaccine development.
Shaw I; Boafo GF; Ali YS; Liu Y; Mlambo R; Tan S; Chen C
J Microencapsul; 2024 May; 41(3):226-254. PubMed ID: 38560994
[TBL] [Abstract][Full Text] [Related]
14. Natural Lipids as Structural Components of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Topical Delivery.
Dobreva M; Stefanov S; Andonova V
Curr Pharm Des; 2020; 26(36):4524-4535. PubMed ID: 32410552
[TBL] [Abstract][Full Text] [Related]
15. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
Okur NÜ; Siafaka PI; Gökçe EH
Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
[TBL] [Abstract][Full Text] [Related]
16. Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes.
Moholkar DN; Kandimalla R; Gupta RC; Aqil F
Cancer Lett; 2023 Jul; 565():216220. PubMed ID: 37209944
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles for hydrophilic drugs.
Mirchandani Y; Patravale VB; S B
J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery.
Das S; Chaudhury A
AAPS PharmSciTech; 2011 Mar; 12(1):62-76. PubMed ID: 21174180
[TBL] [Abstract][Full Text] [Related]
19. A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems.
Duan Y; Dhar A; Patel C; Khimani M; Neogi S; Sharma P; Siva Kumar N; Vekariya RL
RSC Adv; 2020 Jul; 10(45):26777-26791. PubMed ID: 35515778
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles and nanostructured lipid carriers--innovative generations of solid lipid carriers.
Shidhaye SS; Vaidya R; Sutar S; Patwardhan A; Kadam VJ
Curr Drug Deliv; 2008 Oct; 5(4):324-31. PubMed ID: 18855604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
